Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience

AIDS Research and Human Retroviruses, Ahead of Print.

Source: AIDS Research and Human Retroviruses - October 23, 2023 Category: Infectious Diseases Authors: Alessandro Castelli Massimiliano Lanzafame Matteo Morra Marco Bertoldi Andrea Delama Daniela Fait Sandro Vento Source Type: research